Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells.
暂无分享，去创建一个
J. Braess | M. Schaich | T. Illmer | C. Thiede | U. Platzbecker | O. Ottmann | M. Bornhäuser | M. von Bonin | G. Ehninger | P. le Coutre | E. Schleyer | J. Freiberg-Richter | J. Pursche | C. Köhne